Enhanced passive surveillance of influenza vaccination in England, 2016−2017- an observational study using an adverse events reporting card
Influenza is a major public health burden, mainly prevented by vaccination. Recommendations on influenza vaccine composition are updated annually and constant benefit-risk monitoring is therefore needed. We conducted near-real-time enhanced passive surveillance (EPS) for the influenza vaccine, Fluar...
Saved in:
Main Authors: | Simon de Lusignan (Author), Filipa Ferreira (Author), Silvia Damaso (Author), Rachel Byford (Author), Sameera Pathirannehelage (Author), Anne Yeakey (Author), Ivelina Yonova (Author), Anne Schuind (Author), Gael Dos Santos (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2019-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Brand-specific enhanced safety surveillance of GSK's Fluarix Tetra seasonal influenza vaccine in England: 2017/2018 season
by: Simon de Lusignan, et al.
Published: (2020) -
Household presentation of influenza and acute respiratory illnesses to a primary care sentinel network: retrospective database studies (2013-2018)
by: Simon de Lusignan, et al.
Published: (2020) -
Enhanced passive safety surveillance of a quadrivalent inactivated split virion influenza vaccine in Finland during the influenza season 2020/21
by: Olga Syrkina, et al.
Published: (2022) -
Enhanced passive safety surveillance of the quadrivalent inactivated split-virion influenza vaccine (IIV4) in Finland during the 2019/20 influenza season
by: Anne-Laure Chabanon, et al.
Published: (2021) -
Enhanced passive safety surveillance of three marketed influenza vaccines in the UK and the Republic of Ireland during the 2017/18 season
by: Sonja Gandhi-Banga, et al.
Published: (2019)